Related by context. All words. (Click for frequent words.) 54 guidance 48 PDEIS 48 Horizontal Merger Guidelines 48 dioxin reassessment 47 cGMPs 46 Guidance Document 46 Mortgagee Letter #-# 46 Proposing Release 45 FDAAA 45 practices GMPs 45 guidelines 45 ICH E# 45 QbD 45 PPS3 45 AFEP MEDEF 45 Guides Concerning 45 Complete Response Letter 44 Combating Counterfeit Drugs 44 Postmarket 44 PhRMA Code 44 SEC Regulation FD 44 Corporate Governance Principles 44 premarket notification 44 Rating Outlooks 44 exemptive orders 44 Proposed Rulemaking NPRM 44 FSP EITF #-#-# [002] 44 CP#/# 44 Guidance 44 Remuneration Code 43 explanatory memoranda 43 Implementation Guides 43 SEC Regulation SX 43 BCRs 43 Multivariate Index 43 eCTD submission 43 Colin Bowdidge Ph.D. P.Geo 43 National Coverage Determination 43 proposed rulemaking NPRM 43 La.Code Crim.P. art 43 Lamfalussy process 43 inspectional observations 43 Revised Guidance 43 LDTs 43 outlooks 43 QHSR 43 midquarter 43 Interpretative Communication 43 SUPPLEMENTARY INFORMATION 42 Thoresen Review 42 eCTD submissions 42 Circulars 42 pre decisional 42 JECFA 42 contrarian viewpoint 42 petition skimps 42 Mike Magrum P.Eng 42 Penalty Guidelines 42 Regulatory Impact Statement 42 NYSE Rule #A.# 42 Scoping Plan 42 GEIS 42 rulemaking 42 ICH guidelines 42 sNDA submission 42 NPSs 42 ECOFIN Council 42 MDUFMA 42 REMS 42 Communications DDMAC 42 Standards CFATS 42 WDEQ 42 Revised Guidelines 42 Guidelines 42 Manufacturing Practices GMPs 42 preannouncements 42 negative preannouncements 41 recommendations 41 Complete Response Letter CRL 41 Stephanie Kwisnek spokeswoman 41 predecisional 41 FAR clauses 41 directives 41 ANPRM 41 CAIB recommendations 41 Clinger Cohen 41 COSO framework 41 GRI G3 41 Final EIS 41 Product Characteristics 41 Exposure Draft 41 Complete Response letter 41 Regulation FD Sinclair 41 Schedule UTP 41 Silenor NDA 41 compendia 41 USDA FSIS 41 GRI Guidelines 41 Santiago Principles 41 SOX Sarbanes Oxley 41 eCTD format 41 proposed rulemaking 41 PDSs 41 eMDR 41 Interpretive Guidance 41 Recent Accounting Pronouncements 41 CICA Handbook Sections 40 Environment Impact Statement 40 Dietary Reference Intakes 40 Common Minimum Programme CMP 40 ITIL Version 3 40 FFDCA 40 PRIPs 40 authority Gurian Sherman 40 NSAID painkillers 40 Proposed Regulations 40 Proposed Rule 40 Applicant Guidebook 40 OCABR 40 ASX Corporate Governance 40 FAA airworthiness directives 40 Mortgagee Letter 40 BEE codes 40 Auditing Profession 40 SmPC 40 Acquisition Regulation FAR 40 Boiler MACT 40 adopting IFRS 40 Winnemen Wintu tribe 40 Expect flyspeck scrutiny 40 Regulation FD 40 Demotech Performance 40 thisrelease 40 forecasts 40 recommen dations 40 MTFP 40 EU Directive #/#/EC 40 Programmatic Environmental Impact Statement 40 ToRs 40 OFPP 40 IFRS changeover 40 CDRH 40 Board NOSB 40 stakeholder consultations 40 regulations 40 RFS2 40 expressly qualifies 40 Clinical Guideline 40 + +0 40 Acquisition Regulations 40 ANN podcast 40 postmarketing studies 40 Mitigation Strategy 40 CICA Handbook 40 Final Appraisal Determination 40 Transparency Directive 40 TSCA 40 DME MACs 40 Stewardship Code 40 NCVHS 40 FAPIIS 40 MHPAEA 40 FQ3 39 allergen labeling 39 preambles 39 Notified Bodies 39 recommedations 39 F1Q EPS 39 Voluntary Guidelines 39 CGL specification 39 GMPs 39 SOPs 39 OGAC 39 Act FISMA 39 guildelines 39 ideological flashpoints 39 Subpart E 39 Funds Availability NOFA 39 Defence Procurement Procedures 39 Practice Guidelines 39 Deskbook 39 Amending Directive 39 Still Wootan 39 Drug Administration Amendments 39 Medication Guide 39 REACH Regulation 39 Bid increments 39 BC EAO 39 PRM NGO 39 F4Q EPS 39 Interagency Guidance 39 G3 Guidelines 39 Sarbannes Oxley Act 39 Solvency II Directive 39 Council FFIEC 39 Intermezzo ® NDA 39 MIPPA 39 IPPC Directive 39 Tailoring Rule 39 Corrective Action Order 39 Dietary Ingredients 39 FDA Modernization Act 39 ozone NAAQS 39 Quadrennial Defense Review QDR 39 Fund website www.sunamericafunds.com 39 prudential norms 39 AIFMD 39 TheFlyOnTheWall.com subscription required 39 CIM Definition Standards 39 Pulmonary Allergy Drugs 39 Data Sheet MSDS 39 frameworks 39 SACGHS 39 Zacks Consensus Estimates 39 Visible Ops 39 CEAA 39 Michael Steinmann P.Geo 39 IRTPA 39 pro forma EPS 39 workplans 39 IFRIC interpretations 39 employee handbooks 39 Dr. Gulfo 39 ACC AHA SCAI 39 outlook MYEFO 39 ITRS roadmap 39 Airworthiness directives 39 IEEE #.#n specification 39 www.nesteoil.com 39 Carbon Principles 39 CitizenTube ensuring 39 DMEPOS supplier 38 rPA vaccine candidate 38 illustrative examples 38 NDAs 38 MEGs 38 FSP #-# 38 CPSS IOSCO 38 Consultation Document 38 RFCs 38 Reaffirms Fiscal 38 preannouncement 38 roadmaps 38 Mashelkar Committee 38 Revenue Procedure 38 SORP 38 Erik Ostensoe P. Geo 38 Accelerated Approval 38 WS Notification 38 IEEE P# powerline 38 CFATS 38 GAAP Taxonomies 38 resultsof 38 FSP FAS #-# 38 MISRA C + 38 Clinger Cohen Act 38 Motorized Travel 38 SEIS 38 TPSAC 38 Rev. Proc 38 Common Minimum Programme NCMP 38 Administrative Procedures Act 38 patented dPollution Device reconditions 38 thedate hereof 38 IRPAC 38 quaterly 38 NRSROs 38 G7 communiqué 38 Exposure Drafts 38 telavancin NDA 38 ONCHIT 38 FDA 38 QOF indicators 38 thispress release 38 TORs 38 Essential Requirements 38 Orathecin 38 Matritech undertakes 38 Policy Statement 38 DSHEA 38 bargaining Lewenza 38 AFEP MEDEF recommendations 38 Notice #-# [002] 38 BPEL specification 38 Proposed Rule Making 38 intersessional meetings 38 cethromycin NDA 38 condensed consolidated interim 38 revisions 38 definitions 38 earnings preannouncements 38 Appendix B 38 IORP Directive 38 InSight Publisher 38 CAUTIONARY STATEMENT Statements 38 DMAIC 38 Interoperability Standards 38 PDUFA 38 prudential framework 38 rulemakings 38 these windfalls Lunsford 38 Environmental Impact Statements 38 FATCA 38 ADAAA 38 Conduct EICC 38 NCCN Guidelines 38 DESCRIPTION rPath 38 Major Newswire http:/www.majornewswire.com 38 Rev. Rul 38 WEEE Directives 38 ACIP recommendations 38 FDA GRAS 38 regu lations 38 EGTT 38 TJ Termuende P.Geo 38 Exorbitant salaries 38 Frequently Asked Questions FAQs 38 rulings 38 Safe harbor provisions 38 sunset clauses 38 Reg FD 38 Daniel Hoeltgen 38 Regulatory Flexibility Act 38 F#Q# revenues 38 Total Coliform Rule 38 IOSCO Code 38 IPSAS 38 Accession Partnership 38 capitalized minimums 38 ICMJE 38 dosing instructions 38 supplemental EIR 38 Consensus Statement 38 CMSWire speaks 38 Lauren Silvernail 38 MEDPAC 38 NCCN guidelines 38 expectaions 38 guidlines 38 Capital Requirements Directive 38 National Curriculum Framework 38 postmarketing surveillance 38 #QF# 37 please email features@mirror.co.uk 37 TWGs 37 APTIMA HPV assay 37 4BETTER OR WORSE 37 Securities Regulators CESR 37 Decree #/#/ND-CP [001] 37 FASB ASC #-# 37 Whit Cornman spokesman 37 Notice #-# [001] 37 FOP labeling 37 biogeneric drugs 37 SA Asgi SA 37 Hazardous Materials Regulations 37 franchise reacquisitions 37 Section #I 37 captions Item 1A 37 Playbooks 37 Disclaimer Clause 37 Mitigated Negative Declaration 37 BLA filing 37 STIGs 37 vCloud API 37 FY# EPS guidance 37 Explanatory Notes 37 FASB IASB 37 Reaffirms FY# 37 DIRECTOR ORSZAG 37 Earnings Guidance 37 Consultation Paper 37 FY1 37 revises FY# 37 KIID 37 CALGreen 37 sNDAs 37 draft SEIS 37 grammar sticklers everywhere 37 CFR Parts 37 handbooks 37 Machinery Directive 37 prudential regulations 37 http:/www.grants.gov 37 guideline 37 Corporate Governance Code 37 XBRL taxonomy 37 TSX DMM Dynasty 37 Ms. Lewent 37 Incoterms ® 37 Tom Le Veque 37 PEIS 37 pulls Darvon painkiller 37 Mr Siripol 37 codecision procedure 37 NCCN Drugs 37 IRP# 37 CLERP 9 37 directive #/#/EC [002] 37 Java Specification Requests JSRs 37 Value Enhancement Plan 37 outlook 37 PMBOK 37 TSCA reform 37 ASTM ISO 37 footnote disclosures 37 downward revisions 37 ameliorative measures 37 hydrophobic docetaxel prodrug nanoparticle 37 ITIL COBIT 37 CFR § #.# [001] 37 Downtown Revitalization Plan 37 Arbitration Procedure 37 given SMARTView 37 Solvency II directive 37 Policies Procedures 37 Peter Dimmell P.Geo 37 RISDP 37 proposed rulemaking ANPR 37 CPT coding 37 Agria filings 37 GS1 standards 37 Eaton ETN 37 SDEIS 37 operating procedures SOPs 37 MKS Instruments MKSI 37 Scoping Document 37 FSLRC 37 normative framework 37 concurrences 37 FALCPA 37 RoHS directives 37 MMSEA 37 limiters regulatory 37 Position Statement 37 Regulatory Frameworks 37 Investigational Drugs 37 Submission Guidelines 37 postapproval 37 airworthiness directive AD 37 spokeswoman Eryn Witcher 37 F1Q 37 ambiguously worded 37 Mr. Karbe 37 Cobit 37 Pa.RAP 37 ePrivacy Directive 37 FAR Subpart #.# 37 papal encyclicals 37 Heinz Ciesinski 37 Medicaid RACs 37 bibliometrics 37 Macro prudential 37 fatwas 37 ANALYST TAKE Analysts 37 Proposed Rulemaking ANPR 37 looking statementswithin 37 alogliptin NDA 37 SPDs 37 toreflect 37 Food Labelling 37 EIS EIR 37 ITIL ITSM 37 Clifford Cretan ordered 37 OLC memos 37 FY# [001] 37 attestations 37 proformas 37 IBIs 37 JJ Irani Committee 37 Rhyee 37 Forming Consciences 37 FDA Oncologic Drug 37 Plimsoll chart 36 Administrator Interpretation 36 provi sions 36 Gerber Scientific Annual Report 36 FY# Guidance 36 Dean MacEachern P.Geo 36 Voraxaze 36 Supplementary Prospectus 36 PERM Rule 36 Expandable polystyrene 36 F3Q EPS 36 Directives 36 EPS 36 Dietary Guidelines 36 purposive approach 36 Biological Opinion 36 postmarket studies 36 Governmentwide 36 visit www.BYETTA.com 36 ANSI ASHRAE IESNA Standard 36 ISA S# 36 NPRM 36 DSEAR 36 Malegam Committee 36 Transparency Obligations Directive 36 Clinical Practice Guideline 36 DFARS 36 contemporaneous documentation 36 Revises Full 36 worthwhile Schwehm 36 AFI #-# 36 W3C Recommendations 36 nonprecedential 36 F3Q 36 ionophores 36 ADAAG 36 Formal Dispute Resolution 36 determinations 36 Slashes FY# 36 normalized EPS 36 FY# adj 36 #.#g specification 36 xxxi adverse tax 36 EPS estimate 36 perview 36 involve risksand uncertainties 36 IRSAC 36 disbelievers denouncing Muslim 36 Proposed Revisions 36 Mineral Reserves Best Practices 36 FISMA compliance 36 NCCN Guidelines ™ 36 Mofcom 36 NAVMEC 36 positive newsflow 36 ACC AHA ESC 36 specifications 36 Cheaper Medicines Law 36 Interoperability Principles 36 * Withdrew 36 Subpart H 36 § #G#.# 36 CFR #.# c 36 RfP 36 Standards GIPS 36 FAS# R 36 Company website www.gcgaming.com 36 Darzi review 36 uplinking norms 36 downgrades 36 quantifications 36 ecolabels 36 draft EIS 36 ASX Listing Rule #.#A 36 Shari'a principles 36 countercyclical buffers 36 spokesman Tony Plohoros 36 JPDO 36 Practice Recommendations 36 David Gower P.Geo 36 historical facts areforward 36 PRSP II 36 Enabler Releases 36 Balluck 36 integrated passive ASIP 36 Draft SEIS 36 SEIR 36 suggestions recommendations 36 unaudited consolidated interim 36 NCERT syllabus 36 therapeutics ProMetic affinity 36 Competency Model 36 Q4 CY# 36 McCLELLAN Again 36 Specification PAS 36 CICA Accounting Guideline 36 Biophan anticipates 36 STEO 36 HCPCS codes 36 F2Q 36 LSA CCP art 36 SGEIS 36 Enhancement Update SEU 36 RIGScan CR 36 Forecast Scenarios 36 Gord Lacey All 36 companiesâ € ™ 36 NSDS 36 recom mendations 36 sales divestitures recapitalizations 36 BEE Codes 36 NIJ .# 36 Exim Policy 36 Dr. Joshua Schimmer 36 Cognos Performance Blueprints 36 Common Minimum Program 36 Expedited Review 36 comitology 36 commissioning PBC 36 Lowers Q4 36 EIR EIS 36 Antitrust Modernization Commission 36 Quadrennial Defence 36 Std msg charges 36 Wi Fi CERTIFIED #.#n 36 Practice Guideline 36 Core Competencies 36 free StreeTools TM 36 midquarter update 36 GTC undertakes 36 updated NCCN Guidelines 36 FNPRM 36 Pepsi Bottling PBG 36 GPSD 36 press releases 36 DRIs 36 Historic Preservation Ordinance 36 Procurement Policy OFPP 36 Environmental Impact Statement EIS 36 WME ranking 36 Islamic Shariaa 36 Unifill syringe 36 PCI HIPAA SOX 36 tamper resistant packaging 36 nonbinding blueprints 36 lowers FY# EPS 36 communiqués 36 Jim Reddoch 36 JSRs 36 revaccinate according 36 FIFRA 36 ERDs 36 ACAS Code 36 #-# Defaults 36 Agile methodologies 36 Malegam committee 36 analystâ 36 FSA Handbook 36 Contrave NDA 36 ROVNER Well 36 CAMELS rating 36 Counterparty Criteria 36 Watch Updates advisories 36 CFR #.# [006] 36 bioresearch monitoring 36 CCM SectorInvest offers 36 CMIS specification 36 ESAs 36 Regulations.gov 36 Prevent Combat 36 SMMP 36 designations 36 RESEARCH ALONE 36 GS1 EPCglobal 36 Pecoriello wrote 36 European Pharmacopoeia 36 resubmission 36 Exelbine NDA 36 GFSI standards 36 EDDL 36 Uniform Relocation Assistance 36 FRSSE 36 WH crashers 36 Soundness Act 36 Conglomerates sector 36 Issuer Repurchase 36 Cebs 35 Forwardlooking statements 35 RxNorm 35 FAR Clause #.#-# 35 SONET SDH jitter 35 CAUTIONARY STATEMENT Estimates 35 within themeaning 35 infant formula contaminant 35 boilerplate disclaimer 35 SEDAR www.SEDAR.com 35 PowerRating DELISTING REVIEW 35 FedRAMP 35 Listing Rule #.#A 35 Recommended Practices 35 #KB PDF 35 PCAST 35 regulator IRDA 35 MVEIRB 35 Mike Magrum PEng 35 opg margin 35 interdepartmental coordination 35 Requirements Document 35 XSPA 35 IAASB 35 Vyyo assumes 35 PennyStockVille.com encourages readers 35 Response Framework 35 CoPP 35 Malegam 35 Banking Supervision BCBS 35 STEPHEN MORRISON 35 withrespect 35 Underwriter Laboratories UL 35 safe harbor Celera 35 observe Quiet Period 35 Assemblywoman Lieber 35 IASB FASB 35 Vioxx Sharfstein 35 MGCD# clinical trials 35 Textile Labelling Act 35 Ark. Sup 35 analytically rigorous 35 IEPD 35 Tweeted rued 35 Jacksta 35 rulebooks 35 unaudited consolidated balance sheets 35 '# +2' 35 projections 35 biostatistical analysis 35 octroi abolition 35 Common Minimum Programme 35 Recommendations 35 MISRA 35 KDOQI guidelines 35 manuals 35 Cesr 35 SLHCs 35 DOT Hazardous Materials 35 USDA NOP 35 Öko Institut 35 reaffirms FY# revs 35 ests 35 MultiCell bases 35 Pharma Payor benefit 35 may contact mchamplin@infocomm.org 35 FSPs 35 Add.1 35 W3C Recommendation 35 Foltz CDC epidemiologist 35 blanket retroactive immunity 35 midquarter updates 35 Waste Discharge Requirements 35 Position Paper 35 Handbook Sections 35 statements arebased 35 pilot readback error 35 Palatin intends 35 requiring Asthmatx 35 PPS# 35 Primavera P6 Enterprise 35 website www.bancroftfund.com 35 Activities NI #-# 35 trans fat labeling 35 MPFS 35 Decision #/#/EC 35 DPCO 35 Guiding Principles 35 Vapor Intrusion 35 Subsidiary Arrangements 35 reflect HRTE 35 CFR #.# d 35 Psychopharmacologic Drugs Advisory 35 Pfizer respectfully disagrees 35 fineprint 35 FAST SBP 35 CFR § #.# [006] 35 Improvement Amendments 35 NIEs 35 SoP 35 inter ministerial consultation 35 EU RoHS Directive 35 CRZ Notification 35 ACGIH 35 JIC assessments 35 ATEX Directive 35 SOA Maturity Model 35 gulfshorelife.com prior 35 generic biologic 35 Hazardous Waste Regulations 35 Statement EIS 35 spokeswoman Lenore Gelb 35 NIST Smart Grid 35 announcements 35 enforced inconsistently 35 Nick Spoliar 35 Ugur Akinci PhD 35 Product Monograph 35 nonprescription NSAIDs 35 Options Symbology Initiative 35 proforma EPS 35 ASUR filings 35 arebased 35 ZIPI 35 Plans SIPs 35 earnigns 35 Q# revs 35 methodological limitations 35 OSTP 35 www.dea.com 35 EBOM 35 La. Code Civ 35 Work SOW 35 BoxesOS allows 35 DPX Survivac 35 ERGEG 35 aspenONE V7 35 Ucits IV 35 financialresults 35 Nutrition Facts labels 35 #.#-#.# pct [001] 35 otherrisks 35 Administration Regulations EAR 35 Prescribing Information 35 Repurchase Notice 35 submittal 35 Greenhouse Gas Reporting 35 Living wills 35 Dr. Scangos 35 Orderly Liquidation Authority 35 lorcaserin NDA 35 Sumit Dhanda 35 Basel III norms 35 materiality threshold 35 Immunization NACI 35 ecodesign 35 Co MRK MRK 35 gazette notifications 35 spokeswoman Kristen Skopeck 35 CFR #.# [002] 35 www.solosendoscopy.com 35 Rule 2a 7 35 Lok Pal Bill 35 Guideline Update 35 memos justifying 35 Clintrace 35 Polymer Intermediates 35 NCPDP SCRIPT 35 AVDL 35 Discussion Paper 35 CRHI 35 Undersecretary Rand Beers 35 PGxPredict tests 35 Tort Liability Law 35 SDSs 35 UPMIFA 35 Job Descriptions 35 § #B#.# [002] 35 Farmstead Telephone 35 IFRSs 35 auditors KPMG LLP 35 level domains gTLDs 35 Cabinet Lekgotla 35 AIFM Directive 35 nitrates directive 35 Subject Matter Experts 35 KANGAS OK 35 DoD Directive 35 Determinations Panel 35 website www.diamyd.com 35 G# communiqué 35 PCI DSS SOX 35 #CFR 35 nutrition labeling 35 Color Brightness 35 MIMPS 35 DESCRIPTION Red Hat 35 Company NYSE SHW 35 F4Q 35 Integrators List 35 Subtitle D 35 Self Regulatory Principles 35 reports Q3 adj 35 HITSP 35 HPV vaccine GlaxoSmithKline Cervarix 35 EHSMS 35 Reporting Initiative GRI 35 IVGN 35 Stop procrastinating 35 Merck Arcoxia 35 AICC SCORM 35 compliance therewith 35 Regulation SX 35 FY #E [001] 35 Doctrinal Note 35 concerning Alnylam 35 Muken 35 GASB Statement No. 35 Company website www.nashfinch.com 35 codal 35 prescripts 35 CoPs 35 Midterm politicking hovers 35 backtests 35 Guides Q# 35 TMD LCD 35 OIRA 35 Inc MDT MDT 35 GJXDM 35 BEE scorecard 35 Readme file 35 F#Q# 35 exemptive 35 Carers Strategy 35 FATCA provisions 35 Religious Directives 35 CobiT 35 draft SGEIS 35 http:/www.sanmina-sci.com 35 RoHS Directives 35 sheets MSDS 35 SFAS# R 35 Strategic Plan 35 ITworld privacy 35 Sharia'h 35 Medium Term Expenditure Framework 35 Altera Xilinx 35 website www.ndrc.gov.cn 35 TechStat 35 forwardlooking 35 Inc. OTCBB FRHV 35 FQ1 35 binary formats 35 Framework Directive 35 Interconnection Regulation 35 GUIDELINES 35 National Semi NSM 35 G8 communiqué 35 Systemic Interoperability 35 entitled Caution Regarding 35 CarbonNeutral Protocol 35 current NAREIT definition 35 website www.loews.com 35 goods A#M# 35 TRH Annual Report 35 EPCRA 35 Reinsurance Directive 35 MYEFO 34 Block Exemption Regulation 34 NYSE ETY 34 handbook 34 news visit www.aaronwallis.co.uk 34 footnotes endnotes 34 CRZ notification 34 concerning Epigenomics AG 34 website jabil.com 34 Trans Fat Task Force 34 GOI FRB 34 NSDS III 34 programmatic EIS 34 Nonprescription Drugs Advisory 34 Guideline 34 Ronald Peleo Lazar 34 Recovery Ratings RRs 34 www.iconplc.com 34 Key Judgments 34 Supplemental Environmental Impact 34 newsflows 34 Address Discrepancy 34 F2Q EPS 34 MVDP 34 allergenic ingredients 34 ISA#.#a standard 34 theseforward looking 34 Outcome Document 34 Reporting Requirements 34 Fy# 34 terminologies 34 F#Q# EPS 34 iRise visualization 34 Immunisation Practices 34 topic designators 34 CIP TRAMADOL ER 34 dietary guidelines 34 Guidelines WCAG 34 Telework Enhancement Act 34 FSSAI 34 footnotes thereto 34 sees FY opg 34 NASD Rule 34 NYSE MON 34 FASB EITF PCAOB 34 Carnival Plc CUK 34 PPACA 34 Bioterrorism Act 34 Prescription Drug User Fee 34 SBA loan originations 34 broadly 34 Financial Reporting Interpretations 34 constitutes patentable 34 approps 34 Decision ROD 34 proxystatement 34 Technical Specifications 34 Novavax cautions 34 Offer Documentation 34 planogram 34 Altera ALTR 34 Submittals 34 pd ratings 34 VBER 34 CY# EPS estimate 34 Reaffirms Full 34 IAS IFRS accounting 34 Inc XLNX XLNX 34 spokeswoman Diane Katzenberger 34 PCORI 34 reflect Medicago 34 Generic Environmental Impact 34 Xilinx XLNX